Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 2/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.36 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.36 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 3/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.32 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.32 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.32 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.32 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.32 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 2/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13858947 | 1.00 | PDPK1 (0.40) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL19669778 | 1.00 | PDPK1 (0.40) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL13775043 | 1.00 | PDPK1 (0.40) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL7023289 | 0.92 | PDPK1 (0.37) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL584260 | 0.92 | TACR1 (0.38) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL8469404 | 0.91 | LTA4H (0.40) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL25981669 | 0.91 | FGF1 (0.38) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL9058173 | 0.91 | PDPK1 (0.36) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL8831280 | 0.91 | PDPK1 (0.36) | PDPK1MTORSSTR1SSTR2SSTR4 | |
| SCHEMBL8831054 | 0.91 | PDPK1 (0.36) | PDPK1MTORSSTR1SSTR2SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9834574-B2 | Crystalline 3-O-fucosyllactose | GLYCOM A/S (DK) | 2017-12-05 | — | — | US | disclosed |
| EP-2943500-B1 | CRYSTALLINE 3-O-FUCOSYLLACTOSE | GLYCOM AS (DK) | 2017-11-08 | — | — | EP | disclosed |
| EP-2828275-B1 | SYNTHESIS OF THE TRISACCHARIDE 3-O-FUCOSYLLACTOSE AND INTERMEDIATES THEREOF | GLYCOM AS (DK) | 2017-03-01 | — | — | EP | disclosed |
| EP-2417143-B1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | GLYCOM AS (DK) | 2016-12-21 | — | — | EP | disclosed |
| US-20150291642-A1 | CRYSTALLINE 3-O-FUCOSYLLACTOSE | GLYCOM A/S (DK) | 2015-10-15 | — | — | US | disclosed |
| US-9012625-B2 | Method for the synthesis of a trisaccharide | GLYCOM A/S (DK) | 2015-04-21 | — | — | US | disclosed |
| US-20150065702-A1 | Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof | GLYCOM A/S (DK) | 2015-03-05 | — | — | US | disclosed |
| US-20130131334-A1 | METHOD FOR THE SYNTHESIS OF A TRISACCHARIDE | Glycom A/S Danmarks Tekniske Universitet (DK) | 2013-05-23 | — | — | US | disclosed |
| EP-2417143-A1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | Glycom A/S (DK) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010115934-A1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | GLYCOM A/S (DK) | 2010-10-14 | — | — | WO | disclosed |
| US-20090176970-A1 | Preparation of Thiosugars and Their Use | GLYCOFORM LIMITED (GB) | 2009-07-09 | — | — | US | disclosed |
| EP-2007782-A2 | THE PREPARATION OF THIOSUGARS AND THEIR USE | Glycoform Limited (GB) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007091040-A2 | THE PREPARATION OF THIOSUGARS AND THEIR USE | GLYCOFORM LIMITED (GB) | 2007-08-16 | — | — | WO | disclosed |
| US-5869460-A | ANTIINFLAMMATORY AGENTS | SANWA KAGUKU KENKYUSHO CO., LTD. (JP) | 1999-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176970-A1 | Preparation of Thiosugars and Their Use | TST, TREH, FUT6 | PDPK1 4643/4885MTOR 1310/4885SSTR1 2311/4885 |
| US-20130131334-A1 | METHOD FOR THE SYNTHESIS OF A TRISACCHARIDE | UGGT1, FUT6, MAN1B1 | PDPK1 2890/4885MTOR 1403/4885SSTR1 909/4885 |
| US-20150065702-A1 | Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof | FUCA1, FUCA2, FUT6 | PDPK1 4084/4885MTOR 2816/4885SSTR1 541/4885 |
| US-20150291642-A1 | CRYSTALLINE 3-O-FUCOSYLLACTOSE | FUCA2, FUT6, FUCA1 | PDPK1 3280/4885MTOR 3600/4885SSTR1 2689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.